We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RHLD:NYSEResolute Holdings Management Analysis

Data as of 2026-05-19 - not real-time

$106.55

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Resolute Holdings is trading well below its short‑ and medium‑term moving averages, signaling a sustained downtrend despite a recent price rebound toward a key support zone. The Relative Strength Index sits in the oversold region, while the MACD line remains under the signal line, producing a bearish histogram that suggests further downside pressure. Volatility is extremely high and beta is significantly above one, indicating that price swings are amplified relative to the broader market. Fundamental metrics reveal a price‑to‑book ratio that is astronomically elevated, dwarfing peers, while the price‑to‑earnings multiple is modestly below the industry average, creating a mixed valuation picture. Operating margins are negative and free cash flow is in the red, compounded by a debt load that dwarfs the company’s equity base, raising concerns about financial resilience. The firm does not pay a dividend, eliminating any income cushion for shareholders.
The limited press coverage consists mainly of corporate announcements without substantive earnings guidance, offering little new catalyst. With liquidity modestly improving but still below average for its market cap, and with no clear path to improving cash generation, the risk profile remains high. Given the confluence of bearish technical signals, an overvalued balance sheet, and weak operating fundamentals, the outlook is cautious across horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • bearish MACD divergence
  • RSI approaching oversold territory
  • price hovering just above a near‑term support level

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • price-to-book ratio far above industry norms
  • high leverage combined with negative free cash flow
  • persistent volatility and weak price momentum

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • ongoing operating losses and thin margins
  • excessive debt relative to equity
  • absence of dividend and limited cash generation prospects

Key Metrics & Analysis

Financial Health

Revenue Growth292.50%
Profit Margin7.70%
P/E Ratio15.5
ROE1.23%
ROA2.15%
Debt/Equity70.98
P/B Ratio138.4
Op. Cash Flow$60.9M
Free Cash Flow$-58210000
Industry P/E29.1

Technical Analysis

TrendNeutral
RSI32.1
Support$97.88
Resistance$145.35
MA 20$124.46
MA 50$140.55
MA 200$138.88
MACDBearish
VolumeIncreasing
Fear & Greed Index89.09

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta2.17
Volatility86.38%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.